BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 49 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200 | -98.1% | 1,000 | -80.7% | 0.00% | – |
| Q2 2023 | $10,669 | -33.4% | 5,179 | +6.7% | 0.00% | – |
| Q1 2023 | $16,012 | +67.4% | 4,852 | -16.8% | 0.00% | – |
| Q4 2022 | $9,563 | -58.4% | 5,831 | +7.9% | 0.00% | – |
| Q3 2022 | $23,000 | +9.5% | 5,404 | -29.0% | 0.00% | – |
| Q2 2022 | $21,000 | -12.5% | 7,611 | +5.4% | 0.00% | – |
| Q1 2022 | $24,000 | +100.0% | 7,222 | +133.6% | 0.00% | – |
| Q4 2021 | $12,000 | -68.4% | 3,092 | -73.6% | 0.00% | – |
| Q3 2021 | $38,000 | -72.5% | 11,727 | -67.7% | 0.00% | – |
| Q2 2021 | $138,000 | -25.0% | 36,316 | -24.0% | 0.00% | – |
| Q1 2021 | $184,000 | -13.6% | 47,780 | +1.9% | 0.00% | – |
| Q4 2020 | $213,000 | -67.4% | 46,869 | +21.3% | 0.00% | – |
| Q3 2020 | $654,000 | -8.9% | 38,636 | -39.7% | 0.00% | – |
| Q2 2020 | $718,000 | +227.9% | 64,025 | +36.3% | 0.00% | – |
| Q1 2020 | $219,000 | +123.5% | 46,966 | +104.3% | 0.00% | – |
| Q4 2019 | $98,000 | +19.5% | 22,991 | +9.5% | 0.00% | – |
| Q3 2019 | $82,000 | -1.2% | 21,000 | 0.0% | 0.00% | – |
| Q2 2019 | $83,000 | -8.8% | 21,000 | 0.0% | 0.00% | – |
| Q1 2019 | $91,000 | +28.2% | 21,000 | +5.0% | 0.00% | – |
| Q4 2018 | $71,000 | -6.6% | 20,000 | 0.0% | 0.00% | – |
| Q3 2018 | $76,000 | -2.6% | 20,000 | 0.0% | 0.00% | – |
| Q2 2018 | $78,000 | +66.0% | 20,000 | +33.3% | 0.00% | – |
| Q1 2018 | $47,000 | -20.3% | 15,000 | 0.0% | 0.00% | – |
| Q4 2017 | $59,000 | -4.8% | 15,000 | -0.4% | 0.00% | – |
| Q3 2017 | $62,000 | 0.0% | 15,064 | +0.4% | 0.00% | – |
| Q2 2017 | $62,000 | -3.1% | 15,000 | 0.0% | 0.00% | – |
| Q1 2017 | $64,000 | +68.4% | 15,000 | 0.0% | 0.00% | – |
| Q4 2016 | $38,000 | +58.3% | 15,000 | +47.1% | 0.00% | – |
| Q3 2016 | $24,000 | 0.0% | 10,195 | +1.4% | 0.00% | – |
| Q2 2016 | $24,000 | -86.5% | 10,053 | -76.8% | 0.00% | – |
| Q3 2014 | $178,000 | – | 43,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weaver Consulting Group | 130,000 | $437,000 | 0.21% |
| Ikarian Capital, LLC | 304,161 | $1,022,000 | 0.13% |
| ABNER HERRMAN & BROCK LLC | 265,000 | $890,000 | 0.12% |
| S.C. Financial Services, Inc. | 15,285 | $51,000 | 0.06% |
| JMAC ENTERPRISES LLC | 45,430 | $153,000 | 0.04% |
| CFO4Life Group, LLC | 12,000 | $40,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 10,839 | $1,329,000 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 29,186 | $98,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 190,403 | $640,000 | 0.00% |